In addition, eligible holders of HTA operating partnership shares (“OP shares”) will receive a quarterly distribution of OP shares, which corresponds to the dividend in HTA ordinary shares described above.
The amount of common stock dividends that HTA pays to its shareholders is subject to the review and approval of the Board of Directors of the Company at its discretion, and depends on a number of factors, including funds. available for payment of distributions, HTA’s financial condition, capital expenditure requirements and annual distribution requirements necessary to maintain HTA’s status as a real estate investment trust under the Internal Revenue Code. The board of directors of HTA may reduce its dividend rate and HTA cannot guarantee the amount of dividends paid in the future, if any.
Founded in 2006 and listed on
This press release contains certain forward-looking statements. Forward-looking statements are based on current expectations, plans, estimates, assumptions and beliefs, including expectations, plans, estimates, assumptions and beliefs regarding HTA, shareholder value and earnings growth.
The forward-looking statements included in this press release are subject to numerous risks and uncertainties which could cause actual results to differ materially from those expressed or implied in the forward-looking statements. Assumptions relating to the foregoing involve judgments regarding, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict with precision and many of which are beyond HTA’s control. Although HTA believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, the actual results and performance of HTA could differ materially and adversely from those stated in the forward-looking statements. Factors that could have a material adverse effect on HTA’s operations and future prospects include, but are not limited to:
* the Company’s ability to effectively deploy the product of the securities offerings;
* changes in economic conditions affecting the healthcare real estate sector, the commercial real estate market and the credit market;
* competition for the acquisition and development of medical office buildings and other facilities that serve the healthcare industry;
* the Company’s ability to acquire or develop real estate properties, and to successfully operate such properties once acquired or developed;
* pandemics and other health problems, and measures to prevent their spread, including the ongoing COVID-19 pandemic;
* economic fluctuations in certain states in which the Company’s investments are geographically concentrated;
* the financial stability and creditworthiness of the tenants of the Company, including the ability and willingness of the tenants or borrowers of the Company to meet their obligations under their respective contractual agreements with the Company and the potential inability of the Company to assert its rights under its leases during the term of any pandemic;
* the ability and willingness of the tenants of the Company to renew their leases with the Company upon expiration of the leases or the ability of the Company to reposition its properties on identical or better terms in the event of non-renewal or in the event of where the Company exercises its right to replace an existing tenant;
* fluctuations in reimbursements from third-party payers such as Medicare and Medicaid;
* the supply of and demand for properties in operation in the market areas in which the Company operates;
* changes in operating expenses of the Company’s properties, including, but not limited to, expenses for property taxes, property and liability insurance premiums and utility rates;
* the Company’s ability and the ability of its tenants to obtain and maintain adequate property, liability and other insurance from reputable and financially stable suppliers;
* restrictive covenants on certain Company properties subject to land leases which may restrict or limit the use of its properties and the types of tenants to which the Company is able to lease, and the Company’s ability to attract new tenants;
* the impact of damage to Company properties by or increased operating costs associated with catastrophic weather conditions and other natural events and the physical effect of climate change;
* retention of the Company’s management team and its ability to attract and retain key qualified personnel;
* legislative and regulatory changes, including changes to laws governing the taxation of real estate investment trusts (“REITs”) and changes to laws governing the healthcare industry;
* variations in interest rates, including variations resulting from the gradual elimination of the current London Interbank Offered Rate (“LIBOR”)
* the availability of capital and financing;
* restrictive covenants in the Company’s credit facilities;
* changes in the Company’s credit ratings;
* The ability of HTA to remain qualified as a REIT;
* changes in generally accepted accounting principles in
* the risk factors set out in HTA’s most recent annual report on Form 10-K and in HTA’s most recent quarterly reports on Form 10-Q.
Forward-looking statements speak only as of the date they are posted. Except as otherwise provided by federal securities laws, HTA does not undertake to update any forward-looking statements to reflect events or circumstances occurring after the date on which they are made. Due to these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements included in this press release or that may be made elsewhere from time to time by, or on behalf of, HTA.